NanoInk, a company specializing in nanometer-scale manufacturing and applications development for the life sciences and semiconductor industries, has exclusively licensed intellectual property from Arrowhead Research Corporation, a publicly-traded nanotechnology company commercializing new technologies in the life sciences, electronics, and energy arenas. The licensed patent application covers use of surfactants to support NanoInk’s Dip Pen Nanolithography (DPN) technology, which involves deposition of nanoscale materials onto a substrate.
“Our license from Arrowhead Research Corporation, coupled with several recently awarded patents, is helping to protect and strengthen NanoInk’s intellectual property portfolio,” said Dr. Cedric Loiret-Bernal, NanoInk’s Chief Executive Officer. “This intellectual property will play a critical role as we continue to explore the applications of our DPN technology to drive the development of high value end products.”
The licensed technology was developed through Arrowhead’s sponsored research at the laboratory of Dr. Patrick Collier at the California Institute of Technology. “The dip pen nanolithography project was one of the first to be sponsored by Arrowhead, and we have worked with Dr. Collier and Caltech to patent the inventions generated under the agreement,” said R. Bruce Stewart, Chairman of Arrowhead. “We intend to continue to license Arrowhead’s new technologies when the economics make sense, in addition to commercializing products through our subsidiaries.”